European Growth Companies With High Insider Ownership For March 2025

Simply Wall St.
20 Mar

As European markets navigate the complexities of U.S. trade tariffs and monetary policy uncertainties, the pan-European STOXX Europe 600 Index recently saw a decline amid these concerns. In this environment, growth companies with high insider ownership can be particularly appealing to investors, as they often reflect strong alignment between management and shareholder interests, potentially offering resilience in volatile times.

Top 10 Growth Companies With High Insider Ownership In Europe

Name Insider Ownership Earnings Growth
Elicera Therapeutics (OM:ELIC) 27.8% 97.2%
Pharma Mar (BME:PHM) 11.8% 40.8%
Vow (OB:VOW) 13.1% 120.9%
CD Projekt (WSE:CDR) 29.7% 39.1%
Bergen Carbon Solutions (OB:BCS) 12% 50.8%
Elliptic Laboratories (OB:ELABS) 22.6% 88.2%
Devyser Diagnostics (OM:DVYSR) 35.6% 94.7%
Ortoma (OM:ORT B) 27.7% 68.6%
Nordic Halibut (OB:NOHAL) 29.8% 56.3%
Circus (XTRA:CA1) 26% 51.4%

Click here to see the full list of 231 stocks from our Fast Growing European Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Med Life

Simply Wall St Growth Rating: ★★★★★☆

Overview: Med Life S.A. is a private healthcare provider offering services across several Romanian cities, with a market cap of RON3.13 billion.

Operations: The company's revenue is primarily derived from its Clinics segment at RON1.02 billion, followed by Hospitals at RON661.49 million, Corporate services at RON296.97 million, Laboratories at RON295.35 million, Dentistry services at RON125.52 million, and Pharmacies contributing RON69.24 million.

Insider Ownership: 39.3%

Earnings Growth Forecast: 80.6% p.a.

Med Life's earnings surged significantly, with a recent report showing net income rising to RON 25.55 million from RON 3.68 million year-over-year. Despite trading at a substantial discount to its estimated fair value, Med Life's revenue growth is expected to outpace the market but remain below 20% annually. Earnings are forecast to grow significantly over the next three years, although interest payments are not well covered by current earnings levels.

  • Navigate through the intricacies of Med Life with our comprehensive analyst estimates report here.
  • According our valuation report, there's an indication that Med Life's share price might be on the expensive side.
BVB:M Ownership Breakdown as at Mar 2025

Rusta

Simply Wall St Growth Rating: ★★★★★☆

Overview: Rusta AB (publ) is a retailer specializing in home and leisure products across Sweden, Norway, Finland, and Germany, with a market capitalization of SEK10.84 billion.

Operations: The company's revenue is segmented as follows: SEK6.68 billion from Sweden, SEK2.47 billion from Norway, and SEK2.39 billion from other markets.

Insider Ownership: 11.3%

Earnings Growth Forecast: 24.2% p.a.

Rusta's earnings are projected to grow significantly, outpacing the Swedish market, with a forecasted annual growth of 24.2%. Recent results show an increase in net income to SEK 257 million for Q3, up from SEK 243 million year-over-year. Despite trading at a substantial discount to its estimated fair value, insider activity indicates more buying than selling over the past three months. Revenue growth is expected at 9.5% annually, surpassing the broader market rate.

  • Click here to discover the nuances of Rusta with our detailed analytical future growth report.
  • Our valuation report unveils the possibility Rusta's shares may be trading at a discount.
OM:RUSTA Earnings and Revenue Growth as at Mar 2025

Hypoport

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hypoport SE develops and markets technology platforms for the financial services, property, and insurance industries in Germany, with a market cap of approximately €1.11 billion.

Operations: The company's revenue segments include the Insurance Platform, generating €66.60 million.

Insider Ownership: 33.5%

Earnings Growth Forecast: 25.9% p.a.

Hypoport's earnings are projected to grow significantly at 25.9% annually, exceeding the German market's growth rate. Despite revenue growth forecasts of 13.6% per year being below 20%, they still surpass the broader market rate of 5.9%. The company has recently confirmed double-digit growth expectations for 2025, with revenues anticipated to reach at least €640 million and EBIT between €30 million and €36 million, reflecting its robust expansion trajectory without substantial recent insider trading activity.

  • Click to explore a detailed breakdown of our findings in Hypoport's earnings growth report.
  • Our valuation report here indicates Hypoport may be overvalued.
XTRA:HYQ Earnings and Revenue Growth as at Mar 2025

Where To Now?

  • Get an in-depth perspective on all 231 Fast Growing European Companies With High Insider Ownership by using our screener here.
  • Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
  • Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Ready To Venture Into Other Investment Styles?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include BVB:M OM:RUSTA and XTRA:HYQ.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10